PNSA, A Novel C-Terminal Inhibitor of HSP90, Reverses Epithelial–Mesenchymal Transition and Suppresses Metastasis of Breast Cancer Cells In Vitro
Metastasis accounts for the vast majority of deaths in breast cancer, and novel and effective treatments to inhibit cancer metastasis remain urgently developed. The expression level of heat shock protein 90 (HSP90) in invasive breast cancer tissue is higher than in adjacent non-cancerous tissue. In...
Main Authors: | Aotong Zhang, Xin Qi, Fu Du, Guojian Zhang, Dehai Li, Jing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/19/2/117 |
Similar Items
-
Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer
by: Qiaoyun Hou, et al.
Published: (2021-07-01) -
HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance
by: Dan Song, et al.
Published: (2021-05-01) -
Inhibition of Embryonic HSP 90 Function Promotes Variation of Cold Tolerance in Zebrafish
by: Bingshe Han, et al.
Published: (2020-12-01) -
Dissecting Selective Translation of HSP90 mRNA in Mammalian Cells
by: Shaikho, Sarah
Published: (2016) -
Targeting Plasmodium falciparum Heat Shock Protein 90 (PfHsp90): A Strategy to Reverse Antimalarial Resistance
by: Shahinas, Dea
Published: (2012)